Metildigoxin

LANIRAPID 0,1 mg COMPRIMIDOS

0,1 mg comprimidoSpainMarketedAuthorised 30 Sept 1972

In other countries

The same active substances on other registers, the same brand first.

Lanitop 0,1 mg tableteCroatia · tableta · Esteve Pharmaceuticals GmbH, Hohenzollerndamm 150-151, Berlin, NjemačkaSame form
Lanitop Tab 0.1MGSaudi Arabia · Roche DiagnosticsSame form
Lanitop Amp 0.1MG-MLSaudi Arabia · Roche DiagnosticsSame substance
Lanitop Liquid 0.6MG-MLSaudi Arabia · Roche DiagnosticsSame substance

Packs

Pack	Code	Status
LANIRAPID 0,1 mg COMPRIMIDOS , 500 comprimidos	603522
LANIRAPID 0,1 mg COMPRIMIDOS , 50 comprimidos	653426

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Metildigoxin

LANIRAPID 0,1 mg COMPRIMIDOS

0,1 mg comprimidoSpainMarketedAuthorised 30 Sept 1972

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
LANIRAPID 0,1 mg COMPRIMIDOS , 500 comprimidos	603522
LANIRAPID 0,1 mg COMPRIMIDOS , 50 comprimidos	653426

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsAEMPS

Package leafletAEMPS

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Metildigoxin
Strength: 0,1 mg
Dosage form: comprimido
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 30 Sept 1972
Registration: 50560
Marketing authorisation holder: Kern Pharma S.L.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración